IP Library › Granted Patent US 8,765,696
Granted Patent B2
US 8,765,696 · App. 13/255,820 · Granted Jul 1, 2014

Steroid compound

Inventor: Takayuki Ishii (Tokyo, JP)
Assignee: Mikasa Seiyaku Co., Ltd.
C07H15/24
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,765,696
App. No.
13/255,820
Granted
Jul 1, 2014
Kind
B2
Abstract

A steroid compound of the Formula (1): [wherein R 1 represents a group selected from the group consisting of H, CH 3 , C 2 H 5 , C 3 H 7 and CH (CH 3 ) 2 , R 2 represents a group selected from NH 2 , NHAc and OCOR 1 , R 3 represents a group selected from the group consisting of CH 3 , COOCH 3 and CH 2 OCOR 1 .]

Claims (11)

1. A steroid compound of the Formula (1):

[wherein R 1 represents a group selected from the group consisting of H, CH 3 , C 2 H 5 , C 3 H 7 and CH (CH 3 ) 2 , R 2 represents a group selected from NH 2 , NHAc and OCOR 1 , R 3 represents a group selected from the group consisting of CH 3 , COOCH 3 and CH 2 OCOR 1 ].

2. The compound according to claim 1 , wherein R 2 is OCOR 1 and R 3 is CH 2 OCOR 1 .

3. The compound according to claim 1 or 2 , wherein R 1 is CH 3 .

4. The compound according to claim 1 or 2 , wherein said R 1 is H.

5. The compound according to claim 1 or 2 , wherein said R 1 is C 2 H 5 .

6. An anti-inflammatory composition comprising as an effective ingredient the compound according to any one of claims 1 to 2 .

7. The anti-inflammatory composition according to claim 6 , which is an external preparation.

8. The anti-inflammatory composition according to claim 7 , which is a therapeutic agent for asthma to be administered by inhalation, a therapeutic agent for allergic rhinitis to be administered by intranasal administration, a therapeutic agent for arthritis or dermatitis to be administered by topical application, or a therapeutic agent for external ocular inflammatory diseases to be administered by instillation.

9. An arthritis therapeutic composition, comprising as an effective ingredient the compound according to any one of claims 1 to 2 .

10. A therapeutic composition for ulcerative colitis, comprising as an effective ingredient the compound according to any one of claims 1 to 2 .

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 21, 2011
From: ISHII, TAKAYUKI
To: MIKASA SEIYAKU CO., LTD.
Reel/Frame 027263/0034 →
Priority Claims (1)
JP 2009-055172 · Mar 9, 2009 · national
Continuity (1)
Related Publication 20120059158A1 · Mar 8, 2012